Bill > HB51

This bill establishes the Prescription Drug Affordability Board, an independent state agency administratively attached to the Office of Superintendent of Insurance. The board is tasked with developing strategies and recommending regulatory approaches to lower the cost of prescription drugs for consumers, healthcare providers, businesses, and the government. The board will be funded through an annual assessment on licensed manufacturers, wholesale drug distributors, and pharmacy benefits managers, and the funds will be used to cover the board's operational costs. The bill also requires the board to conduct a study on the prescription drug market and submit annual reports with recommendations for legislation to lower drug costs.

Health and Social Services

https://www.nmlegis.gov/Legislation/Legislation?chamber=H&legtype=B&legno=51&year=23